Phillip A Sharp - Net Worth and Insider Trading
Phillip A Sharp Net Worth
The estimated net worth of Phillip A Sharp is at least $140 Million dollars as of 2024-05-01. Phillip A Sharp is the Director of Biogen Inc and owns about 468,033 shares of Biogen Inc (BIIB) stock worth over $101 Million. Phillip A Sharp is also the Director of Alnylam Pharmaceuticals Inc and owns about 266,899 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $39 Million. Details can be seen in Phillip A Sharp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Phillip A Sharp has not made any transactions after 2024-02-29 and currently still holds the listed stock(s).
Transaction Summary of Phillip A Sharp
Phillip A Sharp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Phillip A Sharp owns 4 companies in total, including Alnylam Pharmaceuticals Inc (ALNY) , Syros Pharmaceuticals Inc (SYRS) , and Vir Biotechnology Inc (VIR) among others .
Click here to see the complete history of Phillip A Sharp’s form 4 insider trades.
Insider Ownership Summary of Phillip A Sharp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 2024-02-29 | director |
| SYRS | Syros Pharmaceuticals Inc | 2016-06-29 | director & 10 percent owner |
| VIR | Vir Biotechnology Inc | 2019-10-10 | director |
 | | 2009-06-03 | director |
Phillip A Sharp Latest Holdings Summary
Phillip A Sharp currently owns a total of 2 stocks. Among these stocks, Phillip A Sharp owns 468,033 shares of Biogen Inc (BIIB) as of July 21, 2008, with a value of $101 Million and a weighting of 71.93%. Phillip A Sharp also owns 266,899 shares of Alnylam Pharmaceuticals Inc (ALNY) as of February 29, 2024, with a value of $39 Million and a weighting of 28.07%.
Latest Holdings of Phillip A Sharp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BIIB | Biogen Inc | 2008-07-21 | 468,033 | 215.80 | 101,001,521 |
| ALNY | Alnylam Pharmaceuticals Inc | 2024-02-29 | 266,899 | 147.71 | 39,423,651 |
Holding Weightings of Phillip A Sharp
Phillip A Sharp Form 4 Trading Tracker
According to the SEC Form 4 filings, Phillip A Sharp has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 72,500 shares on July 21, 2008, which brought Phillip A Sharp around $5 Million.
According to the SEC Form 4 filings, Phillip A Sharp has made a total of 6 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 30,000 shares on February 29, 2024, which brought Phillip A Sharp around $5 Million.
Insider Trading History of Phillip A Sharp
- 1
Phillip A Sharp Trading Performance
GuruFocus tracks the stock performance after each of Phillip A Sharp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Phillip A Sharp is -7.4%. GuruFocus also compares Phillip A Sharp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Phillip A Sharp within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Phillip A Sharp's insider trading performs compared to the benchmark.
Performance of Phillip A Sharp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.13 | | | | | |
| Relative Return to S&P 500(%) | -4.39 | | | | | |
Phillip A Sharp Ownership Network
Phillip A Sharp Owned Company Details
What does Alnylam Pharmaceuticals Inc do?
Who are the key executives at Alnylam Pharmaceuticals Inc?
Phillip A Sharp is the director of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include EVP & Chief Commercial Officer Tolga Tanguler , CMO & EVP Dev & Med Affairs Pushkal Garg , and EVP & CLO & Secretary Indrani Lall Franchini .
Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary
Over the past 18 months, Phillip A Sharp made 1 insider transaction in Alnylam Pharmaceuticals Inc (ALNY) with a net sale of 30,000. Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 30,567 shares made by Pushkal Garg , a net sale of 7,095 shares made by Indrani Lall Franchini , and a net sale of 14,604 shares made by Yvonne Greenstreet .
In summary, during the past 3 months, insiders sold 36,501 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 36,501 shares. During the past 18 months, 159,676 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 159,676 shares.
Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alnylam Pharmaceuticals Inc Insider Transactions
Phillip A Sharp Mailing Address
Above is the net worth, insider trading, and ownership report for Phillip A Sharp. You might contact Phillip A Sharp via mailing address: Biogen Inc Legal Department, 14 Cambridge Center, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
